Garuda Therapeutics
PrivateLast Round
Series A
Extension
Mar 4, 2025
Total Funding Raised
$256M
Company Overview
Garuda Therapeutics is a biotechnology company that develops off-the-shelf hematopoietic stem cell therapies to treat blood, bone marrow, immune, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Garuda Therapeutics Comparables
Compare Garuda Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratus Therapeutics | 100% | |
| Cell BioEngines, Inc. | 87% | |
| GC Therapeutics | 77% | |
Garuda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 4, 2025 | ||||
| Series B | Feb 7, 2023 | ||||
| Series A | Sep 23, 2021 | ||||
| Series A | Aug 24, 2021 |
Garuda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ridgeback Capital | Series A |
| Cormorant Asset Management | Series A, Series A Extension, Series B |
| Mass General Brigham Innovation | Series A, Series B |
| OrbiMed | Series A Extension, Series A, Series B |
| Cormorant Capital | Series A |
| Northpond Ventures | Series A Extension, Series A, Series B |
| Alexandria Venture Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2025
$50M raised in Series A Extension round.
- Mar 3, 2025
Avanish Vellanki appointed as new President and Chief Executive Officer.
Garuda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Garuda Therapeutics's valuation, stock price, and market status.